Trial intelligence / Profile preview

Phase II single-blind randomized trial of fospropofol disodium vs propofol for induction and maintenance of general anesthesia in elective surgery

CTR20250859Phase 2Completed

Sponsor
Yichang Humanwell Pharmaceutical Co., Ltd.
Start
Mar 2025
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
Countries
1
01

Overview

A Phase 2 trial of fospropofol disodium, sponsored by Yichang Humanwell Pharmaceutical Co., Ltd.. Started Mar 2025; status: completed.

02

Drugs

fospropofol disodium

Beyond the preview

Go deeper on CTR20250859.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20250859.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call